Treatment with PT2567 reduced cell proliferation from both PAH patient and healthy volunteer derived BOECs (figure 5i) without affecting the rate of cellular apoptosis as determined by caspase-3/7 activity (figure 5j). Here, CASP3 is linked to pulmonary arterial hypertension.